 "Govt signs purchase order with Serum for AstraZeneca vaccine: Report")
India’s government has signed a purchase order with vaccine producer Serum Institute for doses of the Oxford/AstraZeneca COVID-19 vaccine, a source familiar with the matter said on Monday.
Television channel CNBC-TV 18 said the order was for 11 million doses.
The government has also signed a purchase agreement with Indian firm Bharat Biotech for its COVID-19 vaccine, the news channel reported, citing unnamed sources.
Representatives for Serum, Bharat Biotech and India’s health ministry did not immediately respond to Reuters requests for comment.
India’s drug regulator had earlier this month given emergency use approval for both vaccines.
The government aims to secure 600 million doses for India’s vaccination drive that aims to inoculate 300 million citizens over the next six to eight months. The immunization programme is expected to begin on Jan. 16.
At nearly 10.5 million, India has the world’s second highest number of novel coronavirus infections behind the United States, although the country’s rate of increase in cases has been slowing.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%